Development of both human connective tissue-type and mucosal-type mast cells in mice from hematopoietic stem cells with identical distribution pattern to human body

Blood

Volumn 103, Issue 3, 2004, Pages 860-867

  Kambe, Naotomo ^b   Hiramatsu, Hidefumi ^b   Shimonaka, Mika ^b   Fujino, Hisanori ^b   Nishikomori, Ryuta ^b   Heike, Toshio ^b   Ito, Mamoru ^b   Kobayashi, Kimio ^b   Ueyama, Yoshito ^b   Matsuyoshi, Norihisa ^b   Miyachi, Yoshiki ^b   Nakahata, Tatsutoshi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHYMASE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR GAMMA; TRYPTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL MATURATION; CELL TRANSPLANTATION; CONNECTIVE TISSUE; CONTROLLED STUDY; DIABETES MELLITUS; GENE MUTATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LUNG ALVEOLUS; LYMPH NODE; MAST CELL; MOUSE; MUCOSA CELL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; SCID MOUSE; SPLEEN; STOMACH MUCOSA; XENOTRANSPLANTATION;

EID: 9144230590     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-04-1160     Document Type: Article

References (47)

1. Williams CM, Galli SJ. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol. 2000;105:847-859.
2. Galli SJ, Wershil BK. The two faces of the mast cell. Nature. 1996;381:21-22.
3. Nakahata T, Kobayashi T, Ishiguro A, et al. Extensive proliferation of mature connective-tissue type mast cells in vitro. Nature. 1986;324:65-67.
4. Tsuji K, Nakahata T, Takagi M, et al. Effects of interleukin-3 and interleukin-4 on the development of "connective tissue-type" mast cells: interleukin-3 supports their survival and interleukin-4 triggers and supports their proliferation synergistically with interleukin-3. Blood. 1990;75:421-427.
5. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions Proc Natl Acad Sci U S A. 1986;83:4464-4468.
6. Irani AM, Bradford TR, Kepley CL, Schechter NM, Schwartz LB. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem. 1989;37:1509-1515.
7. Saito H, Hatake K, Dvorak AM, et al. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc Natl Acad Sci U S A. 1988;85:2288-2292.
8. Gebhardt T, Sellge G, Lorentz A, Raab R, Manns MP, Bischoff SC. Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release. Eur J Immunol. 2002;32:2308-2316.
9. Furitsu T, Saito H, Dvorak AM, et al. Development of human mast cells in vitro. Proc Natl Acad Sci U S A. 1989;86:10039-10043.
10. Kitamura Y, Shimada M, Hatanaka K, Miyano Y. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature. 1977;268:442-443.
11. Kitamura Y, Matsuda H, Hatanaka K. Clonal nature of mast-cell clusters formed in W/Wv mice after bone marrow transplantation. Nature. 1979;281:154-155.
12. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 1988;335:256-259.
13. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988;241:1632-1639.
14. Ueda T, Tsuji K, Yoshino H, et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000;105:1013-1021.
15. Greiner DL, Shultz LD, Yates J, et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol. 1995;146:888-902.
16. Koyanagi Y, Tanaka Y, Tanaka R, et al. High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection. Leukemia. 1997;11(suppl 3):109-112.
17. Yoshino H, Ueda T, Kawahata M, et al. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice. Bone Marrow Transplant. 2000;26:1211-1216.
18. null mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100:3175-3182.
19. null) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood. 2000;95:3102-3105.
20. - T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol. 1997;158:3578-3586.
21. null mice model. Blood. 2003;102:873-880.
22. + cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J Immunol. 2002;169:204-209.
23. Imai T, Koike K, Kubo T, et al. Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro. Blood. 1991;78;1969-1974.
24. Buhring HJ, Seiffert M, Giesert C, et al. The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3. Blood. 2001;97:3303-3305.
25. Buhring HJ, Simmons PJ, Pudney M, et al. The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors. Blood. 1999;94:2343-2356.
26. Bergstresser PR, Tigelaar RE, Tharp MD. Conjugated avidin identifies cutaneous rodent and human mast cells. J Invest Dermatol. 1984;83:214-218.
27. Bussolati G, Gugliotta P. Nonspecific staining of mast cells by avidin-biotin-peroxidase complexes (ABC). J Histochem Cytochem. 1983;31:1419-1421.
28. KleinJan A, Godthelp T, Blom HM, Fokkens WJ, Fixation with Carnoy's fluid reduces the number of chymase-positive mast cells: not all chymase-positive mast cells are also positive for tryptase. Allergy. 1996;51:614-620.
29. Nakahata T, Tsuji K, Tanaka R, et al. Synergy of stem cell factor and other cytokines in mast cell development. In: Kitamura Y, Yamamoto S, Galli SJ, eds. Biological and Molecular Aspects of Mast Cell and Basophil Differentiation and Function. New York: Elsevier Science Publishers; 1995:13-24.
30. Saito H, Ebisawa M, Tachimoto H, et al. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol. 1996;157:343-350.
31. Kambe N, Kambe M, Chang HW, et al. An improved procedure for the development of human mast cells from dispersed fetal liver cells in serum-free culture medium. J Immunol Methods. 2000;240:101-110.
32. Zhang S, Anderson DF, Bradding P, et al. Human mast cells express stem cell factor. J Pathol. 1998;186:59-66.
33. Longley BJ Jr, Morganroth GS, Tyrrell L, et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med. 1993;328:1302-1307.
34. Irani AM, Schwartz LB. Mast cell heterogeneity. Clin Exp Allergy. 1989;19:143-155.
35. Mitsui H, Furitsu T, Dvorak AM, et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci U S A. 1993;90:735-739.
36. Irani AM, Nilsson G, Miettinen U, et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood. 1992;80:3009-3021.
37. Valent P, Spanblochl E, Sperr WR, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood. 1992;80:2237-2245.
38. Toru H, Eguchi M, Matsumoto R, Yanagida M, Yata J, Nakahata T. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood. 1998;91:187-195.
39. Toru H, Kinashi T, Ra C, Nonoyama S, Yata J, Nakahata T. Interleukin-4 induces homotypic aggregation of human mast cells by promoting LFA-1/ICAM-1 adhesion molecules. Blood. 1997;89:3296-3302.
40. Toru H, Ra C, Nonoyama S, Suzuki K, Yata J, Nakahata T. Induction of the high-affinity IgE receptor (Fc epsilon RI) on human mast cells by IL-4. Int Immunol. 1996;8:1367-1373.
41. Kanbe N, Kurosawa M, Nagata H, Yamashita T, Kurimoto F, Miyachi Y. Production of fibrogenic cytokines by cord blood-derived cultured human mast cells. J Allergy Clin Immunol. 2000;106:S85-90.
42. Kanbe N, Tanaka A, Kanbe M, Itakura A, Kurosawa M, Matsuda H. Human mast cells produce matrix metalloproteinase 9. Eur J Immunol. 1999;29:2645-2649.
43. Girardi M, Lewis J, Glusac E, et al. Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation. J Exp Med. 2002;195:855-867.
44. Christofidou-Solomidou M, Longley BJ, Whitaker-Menezes D, Albelda SM, Murphy GF. Human skin/SCID mouse chimeras as an in vivo model for human cutaneous mast cell hyperplasia. J Invest Dermatol. 1997;109:102-107.
45. Luger TA, Wirth U, Kock A. Epidermal cells synthesize a cytokine with interleukin 3-like properties. J Immunol. 1985;134:915-919.
46. Madden KB, Urban JF Jr, Ziltener HJ, Schrader JW, Finkelman FD, Katona IM. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol. 1991;147:1387-1391.
47. Lantz CS, Boesiger J, Song CH, et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature. 1998;392:90-93.